Characteristics | OS | PFS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | 3-year (%) | Univariate | Multivariate | 3-year (%) | Univariate | Multivariate | ||||
 | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | ||
Extra-regional lymph nodes metastases | ||||||||||
No | 68.7 | Reference | Â | Reference | Â | 26.7 | Reference | Â | Â | Â |
Yes | 51.5 | 2.006 (1.704–3.748) | 0.029 | 2.472 (1.247–4.903) | 0.010 | 17.4 | 1.613 (0.994–2.617) | 0.053 |  |  |
Clinical N stage | Â | Â | 0.002 | Â | 0.001 | Â | Â | 0.001 | Â | 0.007 |
N0 | 83.6 | Reference | Â | Reference | Â | 31.9 | Reference | Â | Reference | Â |
N1 | 66.2 | 2.504 (1.164–5.387) | 0.019 | 2.834 (1.256–6.396) | 0.012 | 21.3 | 1.342 (0.888–2.028) | 0.163 | 1.342 (0.888–2.028) | 0.163 |
N2 | 48.3 | 4.195 (1.972–8.924) | <0.01 | 4.602 (2.055–10.305) | <0.01 | 17.4 | 2.083 (1.353–3.206) | 0.001 | 2.100 (1.364–3.231) | 0.001 |
Fibrinogen (G/L) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≤3.41 | 80.2 | Reference |  | Reference |  | 27.6 | Reference |  |  |  |
> 3.41 | 55.1 | 2.777 (1.593–4.840) | <0.01 | 2.254 (1.246–4.078) | 0.007 | 24.9 | 1.008 (0.720–1.409) | 0.965 |  |  |
Primary tumor resection | ||||||||||
No | 42.8 | Reference | Â | Reference | Â | 28.5 | Reference | Â | Â | Â |
Yes | 69.1 | 0.501 (0.261–0.960) | 0.037 | 0.367 (0.148–0.908) | 0.030 | 24.9 | 1.385 (0.798–2.404) | 0.246 |  |  |
PLR | ||||||||||
≤208.48 | 72.3 | Reference |  |  |  | 28.8 | Reference |  | Reference |  |
> 208.48 | 49.7 | 2.448 (1.448–4.028) | <0.01 | 2.396 (1.391–4.126) | 0.002 | 13.4 | 1.414 (0.985–2.031) | 0.061 | 1.371(0.953–1.972) | 0.09 |